Human T cells that target tumor-specific mutations are attractive for cancer immunotherapy, but obtaining these T cells is challenging. A new study shows that tumor mutation–specific T cells can be isolated from the peripheral blood of patients with melanoma.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Cancer characterization and diagnosis with SERS-encoded particles
Cancer Nanotechnology Open Access 18 October 2017
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Rosenberg, S.A. & Restifo, N.P. Science 348, 62–68 (2015).
Schumacher, T.N. & Schreiber, R.D. Science 348, 69–74 (2015).
van Rooij, N. et al. J. Clin. Oncol. 31, e439–e442 (2013).
Rizvi, N.A. et al. Science 348, 124–128 (2015).
Gros, A. et al. Nat. Med. 22, 433–438 (2016).
Gros, A. et al. J. Clin. Invest. 124, 2246–2259 (2014).
Zanetti, M. J. Immunol. 194, 2049–2056 (2015).
Linnemann, C. et al. Nat. Med. 21, 81–85 (2015).
Tran, E. et al. Science 344, 641–645 (2014).
Haber, D.A. & Velculescu, V.E. Cancer Discov. 4, 650–661 (2014).
Lohr, J.G. et al. Nat. Biotechnol. 32, 479–484 (2014).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Schumacher, T., Scheper, W. A liquid biopsy for cancer immunotherapy. Nat Med 22, 340–341 (2016). https://doi.org/10.1038/nm.4074
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.4074
This article is cited by
-
Cancer characterization and diagnosis with SERS-encoded particles
Cancer Nanotechnology (2017)
-
Pathologists and liquid biopsies: to be or not to be?
Virchows Archiv (2016)